{
  "id": 6560384,
  "title": "Rakovina Therapeutics Announces Appointment of Professor Petra Hamerlik to its Board of Directors",
  "url": "https://urgent.news/2026/09/10/rakovina-therapeutics-announces-appointment-of-professor-petra",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-10T08:01:54.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/rakovina-therapeutics-announces-appointment-of-professor-petra-hamerlik-to-its-board-of-directors"
  },
  "original_language": "en",
  "account": null,
  "summary": "Chair of Translational Neuro-Oncology at the University of Manchester, previously a member of the Company’s Scientific Advisory Board, elected at the 2026 Annual General Meeting VANCOUVER, British Columbia, Sept. 10, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery,…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}